- 19 2019/06
iSCLife® products bring new treatments to pat...
The clinical application known as "Clinical study of human umbilical cord mesenchymal stem cells (19#iSCLife®-CSD) for the treatment of uterine traumatic healing failure" with stem cell product has been approved by the state and fully supported by Professor Zhang Weishe, director of the Department of Obstetrics and Gynecology, Xiangya Hospital.
查看详细
-
08 2019/03New medical technology: iSCLife® stem cells for...
"Clinical study of human umbilical cord mesenchymal stem cells (19#iSCLife-CSD) for the treatment of uterine traumatic healing failure" can be a new boon for patients with uterine traumatic healing, providing patients with the third method of treatment that can cure without surgery. New medical technology - stem cell therapy (iSCLife® stem cell therapeutic products).
查看详细 -
07 2019/03Against liver disease, Professor Guo Lei: iSCLi...
Chinese, SCLnow® people, provide a new technology in disease treatment for patients with liver disease, osteoarthritis and uterine traumatic healing - iSCLife® Stem Cells!
查看详细 -
06 2019/03Daylight through the leaves, SCLnow®
A breeze comesAways warm in heartWhat is the most preciousIn the dusk of memories Looking for the petal of that memoryStill retaining the taste of morning light
查看详细 -
05 2019/03Osteoarthritis is no longer a common disease, s...
Umbilical cord mesenchymal stem cells (19#iSCLife®) are a kind of pluripotent cells with self-replicating and self-renewal ability. They can differentiate into osteoblast, adipoblast and cartilage with nutrient, immunomodulatory and anti-inflammatory effects. The cytokines promote cell proliferation and synthesis of the matrix, and at the same time&#
查看详细 -
04 2019/03SCLnow®, walking against time without fear...
Weather of MarchStill warm as usualWind blows up the pastWalking through SCLFairlylandThe scenery is fluentTurning over the different faces of yearsSuddenly your smile breaks in
查看详细